• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 18, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Treating type 2 diabetes and heart failure

Bioengineer by Bioengineer
June 6, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

American Heart Association Scientific Statement News Brief

DALLAS, June 6, 2019 — People with type 2 diabetes are at an increased risk for heart failure and many people have both diseases, which requires careful medical management.

A scientific statement from the American Heart Association and the Heart Failure Society of America brings the management of both diabetes and heart failure into one document and describes new approaches to medications, lifestyle modifications as well as highlighting the importance of multi-disciplinary care that includes physicians, nurses, registered dieticians, social workers and other allied professionals.

The statement is published in the American Heart Association journal Circulation.

###

Authors are: writing group chair Shannon M. Dunlay, M.D., M.S., co-chair

Michael M. Givertz, M.D., David Aguilar, M.D.; Larry A. Allen, M.D., M.H.S.; Michael Chan, M.B.B.S.; Akshay S. Desai, M.D., M.P.H.; Anita Deswal, M.D., M.P.H.; Victoria Vaughan Dickson, Ph.D., R.N.; Mikhail N. Kosiborod, M.D.; Carolyn L. Lekavich, Ph.D., M.S.N., Rozalina G. McCoy, M.D., M.S.; Robert J. Mentz, M.D.; Ileana L. Piña, M.D., M.P.H. Author disclosures are on the manuscript.

Additional Resources:

  • After June 6, view the manuscript online.
  • Prevalence of Cardiovascular Disease Among US Adults (20+ years) with Diabetes in the United States (1999-2016)
  • Trends in Prevalence of Diabetes Awareness, Treatment, and Control in the United States (1999-2016)
  • Prevalence of Prediabetes and Diabetes in the United States (1999-2016)
  • Angela Bassett joins Know Diabetes by Heart, calling those living with type 2 diabetes and cardiovascular disease to share their stories
  • Know Diabetes by Heart™
  • Follow AHA/ASA news on Twitter @HeartNews

The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.

About the American Heart Association

The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies, and share lifesaving resources and information. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.

Media Contact
Darcy Spitz
[email protected]

Related Journal Article

https://newsroom.heart.org/news/treating-type-2-diabetes-and-heart-failure?preview=50c4d269bd00c2a595f4c82488ba9238
http://dx.doi.org/10.1161/CIR.0000000000000691

Tags: CardiologyMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

AlphaCD: Precise ML Model for 21,335 Cytidine Deaminases

AlphaCD: Precise ML Model for 21,335 Cytidine Deaminases

August 18, 2025
Link Between Minor and Visual Hallucinations in Parkinson’s

Link Between Minor and Visual Hallucinations in Parkinson’s

August 18, 2025

SARS-CoV-2 Survival and Spread in Aerosol Chamber

August 18, 2025

How One Researcher Is Developing Solutions to Protect Pets from Accidental Cocaine Ingestion

August 18, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    140 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    80 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    59 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Blocking c-Abl Halts Glioma Cell Growth

MoS2/NC Composite: A Breakthrough Lithium Battery Anode

Digital Pathology Reveals Pancreatic Cancer Risks

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.